DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Depakote (Divalproex) - Hospitalization - Suspected Cause - Side Effect Reports

 
 



Index of reports > Hospitalization (194)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Depakote (Divalproex) hospitalization. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 194   Next >>

Possible Depakote side effects in male

Reported by a physician from United States on 2012-08-21

Patient: male

Reactions: White Blood Cell Count Decreased, Hospitalisation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakote

Keppra

Vimpat
    Indication: Convulsion



Possible Depakote side effects in 59 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-21

Patient: 59 year old female, weighing 83.5 kg (183.7 pounds)

Reactions: C-Reactive Protein Increased, Drug Interaction, Muscular Weakness, Rash Maculo-Papular, Stevens-Johnson Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakote
    Dosage: 750 mg, tid
    Administration route: Oral
    Indication: Bipolar Disorder

Lamotrigine
    Dosage: 50 mg, bid
    Administration route: Oral
    Indication: Bipolar Disorder

Other drugs received by patient: Quetiapine; Hydroxychloroquine Sulfate; Aspirin; Simvastatin; Venlafaxine



Possible Depakote side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-21

Patient: male

Reactions: Abnormal Behaviour, Aggression

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakote
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2011-10-24

Equanil
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2011-10-24

Exelon
    Indication: Product Used FOR Unknown Indication
    End date: 2011-01-01

Tiapridal
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Trimeprazine Tartrate
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2011-10-24

Xanax
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Polyethylene Glycol; Digoxin



Possible Depakote side effects in 59 year old female

Reported by a physician from United Kingdom on 2012-08-20

Patient: 59 year old female, weighing 83.5 kg (183.7 pounds)

Reactions: Drug Interaction, Muscular Weakness, Stevens-Johnson Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakote
    Administration route: Oral
    Indication: Bipolar Disorder

Lamotrigine
    Administration route: Oral
    Indication: Bipolar Disorder

Other drugs received by patient: Simvastatin; Venlafaxine; Quetiapine; Aspirin; Hydroxychloroquine Sulfate



Possible Depakote side effects in 59 year old female

Reported by a physician from United Kingdom on 2012-08-20

Patient: 59 year old female, weighing 83.5 kg (183.7 pounds)

Reactions: Drug Interaction, Muscular Weakness, Stevens-Johnson Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakote
    Administration route: Oral
    Indication: Bipolar Disorder

Lamotrigine
    Administration route: Oral
    Indication: Bipolar Disorder

Other drugs received by patient: Simvastatin; Quetiapine; Hydroxychloroquine Sulfate; Aspirin; Venlafaxine



Possible Depakote side effects in male

Reported by a consumer/non-health professional from Brazil on 2012-08-16

Patient: male

Reactions: Somnolence, Convulsion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-01-01

Depakote
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-01-01
    End date: 2010-01-01

Other drugs received by patient: Lamotrigine; Clobazam



Possible Depakote side effects in 59 year old female

Reported by a physician from United Kingdom on 2012-08-16

Patient: 59 year old female

Reactions: C-Reactive Protein Increased, Muscular Weakness, Drug Interaction, Rash Maculo-Papular, Stevens-Johnson Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakote
    Indication: Bipolar Disorder

Lamotrigine
    Indication: Bipolar Disorder

Other drugs received by patient: Simvastatin; Hydroxychloroquine Sulfate; Quetiapine; Aspirin; Venlafaxine



Possible Depakote side effects in 59 year old female

Reported by a physician from United Kingdom on 2012-08-10

Patient: 59 year old female, weighing 83.5 kg (183.7 pounds)

Reactions: C-Reactive Protein Increased, Drug Interaction, Muscular Weakness, Rash Maculo-Papular, Stevens-Johnson Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakote
    Dosage: 2250mg per day
    Administration route: Oral
    Indication: Bipolar Disorder

Lamotrigine
    Dosage: 100mg per day
    Administration route: Oral
    Indication: Bipolar Disorder

Other drugs received by patient: Hydroxychloroquine Sulfate; Venlafaxine; Simvastatin; Quetiapine; Aspirin



Possible Depakote side effects in 59 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-09

Patient: 59 year old female, weighing 83.5 kg (183.7 pounds)

Reactions: Drug Interaction, Stevens-Johnson Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakote
    Dosage: 750 mg, 3 in 1 d, oral
    Administration route: Oral
    Indication: Bipolar Disorder

Lamotrigine
    Dosage: 50 mg, 2 in 1 d, oral
    Administration route: Oral
    Indication: Bipolar Disorder

Other drugs received by patient: Venlafaxine HCL; Simvastatin; Quetiapine Fumarate; Hydroxychloroquine Sulfate; Aspirin



Possible Depakote side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-09

Patient: female

Reactions: Weight Increased, Hospitalisation, Loss of Employment, Alopecia, Loss of Consciousness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakote



Possible Depakote side effects in

Reported by a physician from United States on 2012-08-09

Patient:

Reactions: White Blood Cell Count Decreased, Hospitalisation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakote

Keppra

Vimpat



Possible Depakote side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-08

Patient: female

Reactions: Agitation, Headache, Mania, Fatigue, Malaise, Hospitalisation, Anger, Depression, Tachyphrenia, Psychomotor Hyperactivity, Restlessness, Motor Dysfunction, Anxiety, Irritability, Panic Attack, Insomnia, Feeling Jittery, Feeling Abnormal

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakote
    Indication: Product Used FOR Unknown Indication

Klonopin
    Dosage: drug use on and off for 21 years, upped from 1.5mg to 3mg daily
    Indication: Mania

Klonopin
    Indication: Bipolar Disorder

Klonopin

Other drugs received by patient: Restoril



Possible Depakote side effects in female

Reported by a lawyer from United States on 2012-08-08

Patient: female

Reactions: Cleft LIP, Conductive Deafness, Convulsion, Emotional Distress, Speech Disorder, Cleft Palate, Developmental Delay, Social Avoidant Behaviour, Otitis Media, Dacryostenosis Congenital, Attention Deficit / Hyperactivity Disorder, Eustachian Tube Dysfunction

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakote
    Indication: Foetal Exposure During Pregnancy

Topamax
    Indication: Foetal Exposure During Pregnancy
    Start date: 2004-11-24
    End date: 2005-02-24

Other drugs received by patient: Multi-Vitamins; Synthroid



Possible Depakote side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-06

Patient: female

Reactions: Cleft LIP, Emotional Distress, Speech Disorder, Cleft Palate, Social Avoidant Behaviour, Developmental Delay, Otitis Media, Dacryostenosis Congenital, Attention Deficit / Hyperactivity Disorder, Eustachian Tube Dysfunction

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakote
    Indication: Foetal Exposure During Pregnancy

Topamax
    Indication: Foetal Exposure During Pregnancy
    Start date: 2004-11-24
    End date: 2005-02-24

Other drugs received by patient: Multi-Vitamins; Synthroid



Possible Depakote side effects in 61 year old male

Reported by a physician from United States on 2012-07-26

Patient: 61 year old male, weighing 76.2 kg (167.6 pounds)

Reactions: Lymphocyte Count Increased, Weight Decreased, Obsessive-Compulsive Disorder, Moderate Mental Retardation, Haematocrit Decreased, Granulocytopenia, Mean Cell Haemoglobin Concentration Increased, Thrombocytopenia, Oxygen Saturation Decreased, Lethargy, Hypotension, Pancytopenia, Deafness Neurosensory, Cognitive Disorder, Monocyte Count Increased, Haemoglobin Decreased, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakote
    Dosage: 1500 mg, bid
    Indication: Schizoaffective Disorder
    End date: 2011-12-03

Fanapt
    Dosage: 12 mg, bid
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2011-03-01
    End date: 2011-12-03

Other drugs received by patient: Ammonium Lactate; Gabapentin; Gabapentin; Loperamide; Metformin Hydrochloride; Tear Drop; Eucerin Creme; Famotidine; Hydrocodone Bitartrate and Acetaminophen; Iloperidone; Levothyroxine Sodium; BEN GAY; Fenofibrate; Selenium Sulfide; Divalproex Sodium; Famotidine; Gabapentin; Levothyroxine Sodium; Metformin Hydrochloride; Bisacodyl; Iloperidone; Fenofibrate; Gabapentin; Acetaminophen; Benztropine Mesylate; Calcium Carbonate W / Vitamin D NOS; Zinc Oxide Ointment



Possible Depakote side effects in 61 year old male

Reported by a pharmacist from United States on 2012-07-25

Patient: 61 year old male, weighing 168.0 kg (369.6 pounds)

Reactions: Lymphocyte Count Increased, Weight Decreased, Obsessive-Compulsive Disorder, Moderate Mental Retardation, Nutritional Condition Abnormal, Haematocrit Decreased, RED Blood Cell Count Decreased, Mean Cell Haemoglobin Concentration Increased, Thrombocytopenia, Oxygen Saturation Decreased, Lethargy, White Blood Cell Count Decreased, Hypotension, Deafness Neurosensory, Monocyte Count Increased, Cognitive Disorder, Haemoglobin Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakote
    Dosage: 1500 mg, bid
    Administration route: Oral
    Indication: Schizoaffective Disorder

Fanapt
    Dosage: 12 mg, bid
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2011-03-01

Other drugs received by patient: Gabapentin; Bengay Ultra Strength CRM; Benztropine Mesylate; Hydrocodone; Benztropine Mesylate; Gabapentin; Gabapentin; Famotidine; Gabapentin; Levothyroxine Sodium; Divalproex Sodium; Iloperidone; Divalproex Sodium; Famotidine; Iloperidone; Metformin Hydrochloride



Possible Depakote side effects in female

Reported by a consumer/non-health professional from Japan on 2012-07-24

Patient: female

Reactions: Blood Pressure Increased, Weight Decreased, Blood Count Abnormal, Cystitis, Loss of Consciousness, Burning Sensation, Palpitations, Ingrowing Nail, Cholecystectomy, Abdominal Distension, Arteriosclerosis Coronary Artery, TOE Operation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Atacand
    Dosage: 32 mg, unk
    Indication: Product Used FOR Unknown Indication

Avapro
    Indication: Hypertension

Bactrim
    Indication: Product Used FOR Unknown Indication

Benicar
    Dosage: unk
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-01-01

Bystolic
    Indication: Product Used FOR Unknown Indication

Cardizem
    Indication: Product Used FOR Unknown Indication

Cipro
    Indication: Product Used FOR Unknown Indication

Depakote
    Dosage: unk
    Indication: Convulsion
    Start date: 1996-01-01

Dilantin
    Dosage: unk
    Indication: Product Used FOR Unknown Indication
    Start date: 1996-01-01

Diovan
    Indication: Product Used FOR Unknown Indication

Furosemide
    Indication: Product Used FOR Unknown Indication

Hydrochlorothiazide
    Indication: Product Used FOR Unknown Indication

Levaquin
    Indication: Product Used FOR Unknown Indication

Lidocaine
    Dosage: unk
    Indication: Anaesthesia
    Start date: 2010-05-13
    End date: 2010-05-13

Lisinopril
    Indication: Product Used FOR Unknown Indication

Losartan Potassium
    Indication: Product Used FOR Unknown Indication

Macrobid
    Indication: Product Used FOR Unknown Indication

Norvasc
    Dosage: 5 mg, bid
    Administration route: Oral
    Start date: 2010-01-01

Norvasc
    Dosage: 5 mg/daily
    Administration route: Oral
    Start date: 1997-01-01

Norvasc
    Dosage: 2.5 mg/daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 1995-01-01

Reglan
    Indication: Product Used FOR Unknown Indication

Xanax
    Dosage: 0.5 df/day
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Levothyroxine Sodium; Clonidine



Possible Depakote side effects in 43 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-24

Patient: 43 year old male

Reactions: Cytolytic Hepatitis, Pyrexia, Drug Rash With Eosinophilia and Systemic Symptoms, Toxic Skin Eruption

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakote

Other drugs received by patient: Ditropan; Foradil; Tegretol; Imovane; Theralene; Pulmicort; Loxapine HCL; Ciprofloxacin HCL



Possible Depakote side effects in 6 year old male

Reported by a pharmacist from United States on 2012-07-20

Patient: 6 year old male, weighing 22.0 kg (48.4 pounds)

Reactions: Pancreatitis Acute, Thirst, Pyrexia, Haemoglobin Decreased, Ileus, Pancreatic Pseudocyst, Hypoxia, Pleural Effusion, Pancreatitis Haemorrhagic

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakote



Possible Depakote side effects in

Reported by a individual with unspecified qualification from United States on 2012-07-17

Patient:

Reactions: Circumstance or Information Capable of Leading To Medication Error, Wrong Drug Administered, Drug Dispensing Error

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakote

Depakote



Possible Depakote side effects in 57 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-10

Patient: 57 year old female

Reactions: Mixed Liver Injury

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ceftriaxone
    Indication: Lung Disorder
    Start date: 2012-03-09
    End date: 2012-03-15

Depakote
    Administration route: Oral
    Start date: 2012-03-13
    End date: 2012-03-19

Depakote
    Administration route: Oral
    Indication: Mania
    Start date: 2012-03-09
    End date: 2012-03-12

Other drugs received by patient: Atarax; Solian



Possible Depakote side effects in 52 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-09

Patient: 52 year old male

Reactions: Pancreatitis Acute, Circulatory Collapse, Respiratory Distress

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Aspirin
    Administration route: Oral
    Indication: Cerebrovascular Accident

Baclofen
    Indication: Cerebrovascular Accident

Depakote
    Administration route: Oral
    Indication: Epilepsy
    End date: 2012-02-28

Diprivan
    Indication: Anaesthesia
    Start date: 2012-02-27
    End date: 2012-02-27

Pipamperone
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication



Possible Depakote side effects in male

Reported by a physician from United States on 2012-07-09

Patient: male, weighing 147.9 kg (325.3 pounds)

Reactions: Fatigue, Adverse Event, Abnormal Behaviour, Dizziness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakote
    Indication: Product Used FOR Unknown Indication

Lithium Carbonate
    Indication: Product Used FOR Unknown Indication

Risperdal
    Dosage: 2 mg in am and 4 mg in pm
    Administration route: Oral
    End date: 1997-01-01

Risperdal
    Dosage: 2 mg in am and 4 mg in pm
    Administration route: Oral
    End date: 2012-01-01

Risperdal
    Dosage: 2 mg in am and 4 mg in pm
    Administration route: Oral
    Indication: Psychotic Behaviour
    End date: 1987-01-01

Risperidone
    Indication: Product Used FOR Unknown Indication

Topamax
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2012-01-01

Topiramate
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication



Possible Depakote side effects in female

Reported by a physician from United Kingdom on 2012-07-03

Patient: female

Reactions: Mania, Mental Impairment, Psychotic Disorder, Dysphagia, Sedation, Thyroid Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakote
    Dosage: 1500 mg

Depakote
    Dosage: 1000 mg
    Indication: Bipolar Disorder

Lithium Carbonate
    Indication: Bipolar Disorder

NEO-Mercazole TAB
    Dosage: 20 mg
    Indication: Bipolar Disorder

Olanzapine
    Indication: Bipolar Disorder

Quetiapine Fumarate
    Dosage: 750 mg

Quetiapine Fumarate
    Dosage: 300 mg
    Indication: Bipolar Disorder



Possible Depakote side effects in

Reported by a consumer/non-health professional from United States on 2012-07-02

Patient:

Reactions: Anxiety, Cardiac Flutter, Atrial Fibrillation

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Depakote



Possible Depakote side effects in 58 year old female

Reported by a consumer/non-health professional from United States on 2012-07-02

Patient: 58 year old female, weighing 162.0 kg (356.4 pounds)

Reactions: Mania, Weight Increased, Vitamin D Decreased, Mental Disorder, Weight Fluctuation, Paraesthesia, Thyroid Function Test Abnormal

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakote
    Indication: Mania
    Start date: 1998-01-01

Depakote
    Indication: Bipolar Disorder
    Start date: 1998-01-01

Depakote
    Indication: Mania
    Start date: 2005-01-01

Depakote
    Indication: Bipolar Disorder
    Start date: 2005-01-01

Lithium Carbonate
    Dosage: 300 mg; bid,po
    Administration route: Oral
    Indication: Mania
    Start date: 2012-06-08

Lithium Carbonate
    Dosage: 300 mg; bid,po
    Administration route: Oral
    Indication: Bipolar Disorder
    Start date: 2012-06-08

Lithium Carbonate
    Indication: Mania
    Start date: 1998-01-01

Lithium Carbonate
    Indication: Bipolar Disorder
    Start date: 1998-01-01

Lithium Carbonate
    Indication: Mania
    Start date: 1995-01-01

Lithium Carbonate
    Indication: Bipolar Disorder
    Start date: 1995-01-01

Other drugs received by patient: Clonazepam; Seroquel



Possible Depakote side effects in 32 year old female

Reported by a physician from France on 2012-06-30

Patient: 32 year old female

Reactions: Intentional Overdose, Hyperammonaemia, Miosis, Tachycardia, Suicide Attempt, Toxicity To Various Agents, Hypokalaemia, Loss of Consciousness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakote
    Dosage: ingested 50 enteric-coated tablets of valproic acid 500mg
    Indication: Suicide Attempt

Olanzapine
    Dosage: ingested unknown amount of olanzapine



Possible Depakote side effects in female

Reported by a consumer/non-health professional from France on 2012-06-29

Patient: female

Reactions: Abdominal Pain, Weight Decreased, Urinary Incontinence, Blood Count Abnormal, Headache, Loss of Consciousness, Palpitations, Feeling Hot, Ingrowing Nail, Gallbladder Disorder, Nervousness, Anaemia, Hypoaesthesia, Gastric Disorder, Convulsion, Insomnia, Cholecystectomy, Platelet Count Decreased, Drug Ineffective, Blood Triglycerides Increased, Drug Interaction, Micturition Frequency Decreased, Fall, Arterial Occlusive Disease, Dizziness, TOE Operation, Kidney Infection, Blood Pressure Increased, Lung Neoplasm, Cystitis, Arteriogram Coronary Abnormal, Full Blood Count Decreased, Burning Sensation, Carbuncle, Hypertension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Atacand
    Dosage: 32 mg, unk
    Administration route: Oral
    Indication: Renal Disorder
    Start date: 1995-01-01

Avapro
    Dosage: unk
    Indication: Hypertension

Bactrim
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Benicar
    Dosage: unk
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-01-01

Cardizem
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Ciprofloxacin HCL
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Depakote
    Dosage: unk
    Indication: Convulsion
    Start date: 1995-01-01
    End date: 2004-01-01

Dilantin
    Dosage: unk
    Indication: Convulsion
    Start date: 1995-01-01

Diovan
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Furosemide
    Dosage: 20 mg, unk
    Indication: Product Used FOR Unknown Indication

Furosemide
    Dosage: unk

Hydrochlorothiazide
    Dosage: unk
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-03-07

Levaquin
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Lidocaine
    Dosage: unk
    Indication: Anaesthesia
    Start date: 2010-05-13
    End date: 2010-05-13

Lisinopril
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Losartan Potassium
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Macrobid
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Nebivolol
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Nopalea
    Dosage: unk
    Indication: Musculoskeletal Pain
    Start date: 2010-01-01

Nopalea
    Indication: Blood Triglycerides Increased

Norvasc
    Dosage: 2.5 mg/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 1994-01-01

Norvasc
    Dosage: 0.5 mg, unk
    Administration route: Oral

Norvasc
    Dosage: 2.5 mg, unk
    Administration route: Oral
    Start date: 2010-07-19
    End date: 2010-07-21

Norvasc
    Dosage: 0.5 mg, unk
    Administration route: Oral
    Start date: 2010-07-22

Norvasc
    Dosage: 5 mg, bid
    Administration route: Oral
    Start date: 2010-01-01

Norvasc
    Dosage: 5 mg/day
    Administration route: Oral
    End date: 1997-01-01

Reglan
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Toprol-XL
    Dosage: 25 mg/day
    Administration route: Oral
    Indication: Heart Rate Abnormal

Toprol-XL
    Indication: Flushing

Xanax
    Dosage: 0.5 mg/day
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Nitroglycerin; Clonidine; Metoprolol Succinate; Ascorbic Acid; Levothyroxine Sodium



Possible Depakote side effects in female

Reported by a consumer/non-health professional from United States on 2012-06-28

Patient: female, weighing 63.6 kg (139.8 pounds)

Reactions: Abdominal Pain, Weight Decreased, Urinary Incontinence, Blood Count Abnormal, Headache, Loss of Consciousness, Palpitations, Feeling Hot, Ingrowing Nail, Gallbladder Disorder, Nervousness, Anaemia, Hypoaesthesia, Gastric Disorder, Convulsion, Insomnia, Cholecystectomy, Platelet Count Decreased, Drug Ineffective, Blood Triglycerides Increased, Drug Interaction, Micturition Frequency Decreased, Fall, Dizziness, Arterial Occlusive Disease, Kidney Infection, TOE Operation, Blood Pressure Increased, Lung Neoplasm, Arteriogram Coronary Abnormal, Cystitis, Full Blood Count Decreased, Haemoglobin Decreased, Burning Sensation, Carbuncle, Hypertension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Amlodipine Besylate
    Administration route: Oral
    Start date: 1997-01-01

Amlodipine Besylate
    Administration route: Oral
    Start date: 2010-01-01

Amlodipine Besylate
    Administration route: Oral
    Start date: 2010-07-19
    End date: 2010-07-21

Amlodipine Besylate
    Administration route: Oral

Amlodipine Besylate
    Administration route: Oral
    Start date: 2010-07-22

Amlodipine Besylate
    Administration route: Oral
    Indication: Hypertension
    Start date: 1994-01-01

Atacand
    Dosage: 32mg daily
    Administration route: Oral
    Indication: Renal Disorder
    Start date: 1995-01-01

Atacand
    Administration route: Oral
    Start date: 2011-09-01

Atacand

Avapro
    Indication: Hypertension

Bactrim
    Indication: Product Used FOR Unknown Indication

Benicar
    Dosage: film-coated
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-01-01

Cardizem
    Dosage: extended release
    Indication: Product Used FOR Unknown Indication

Ciprofloxacin Hydrochloride
    Indication: Product Used FOR Unknown Indication

Depakote
    Indication: Convulsion
    Start date: 1995-01-01
    End date: 2004-01-01

Furosemide
    Indication: Product Used FOR Unknown Indication

Furosemide

Hydrochlorothiazide
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-03-07

Levaquin
    Indication: Product Used FOR Unknown Indication

Lidocaine
    Indication: Ingrowing Nail
    Start date: 2010-05-13
    End date: 2010-05-13

Lidocaine
    Indication: Anaesthesia

Lisinopril
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Losartan Potassium
    Indication: Product Used FOR Unknown Indication

Macrobid
    Indication: Product Used FOR Unknown Indication

Nebivolol Hydrochloride
    Indication: Product Used FOR Unknown Indication

Nopalea (Plant Alkaloids and Other Natural Products)
    Indication: Arthralgia
    Start date: 2010-01-01

Nopalea (Plant Alkaloids and Other Natural Products)
    Indication: Blood Triglycerides Increased

Phenytoin
    Indication: Convulsion
    Start date: 1995-01-01

Reglan
    Indication: Product Used FOR Unknown Indication

Toprol-XL
    Indication: Flushing

Toprol-XL
    Dosage: 25mg daily
    Administration route: Oral
    Indication: Heart Rate Abnormal

Valsartan
    Indication: Product Used FOR Unknown Indication

Xanax
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Levothyroxine Sodium; Clonidine; Metoprolol Succinate; Clonidine



Possible Depakote side effects in female

Reported by a physician from United States on 2012-06-28

Patient: female, weighing 65.8 kg (144.8 pounds)

Reactions: Confusional State, Bedridden, Body Mass Index Increased, Victim of Spousal Abuse, Weight Loss Poor, Diabetes Mellitus, Parkinson's Disease, Weight Increased, Speech Disorder, Impaired Self-Care, Neck Pain, Fibromyalgia, Obesity, Dizziness, Depression, Back Pain, Psychomotor Hyperactivity, Pain in Extremity, Partner Stress, Sexual Relationship Change, Self Injurious Behaviour, Hepatic Steatosis, Tremor, Anxiety, Panic Attack, Bipolar Disorder, Neoplasm Malignant, Alopecia, Insomnia, Mental Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakote
    Dosage: one daily at night
    Administration route: Oral
    Indication: Bipolar Disorder
    Start date: 2005-01-01
    End date: 2009-01-01

Depakote
    Start date: 1999-01-01

Other drugs received by patient: Cymbalta; Risperdal; Clonazepam; Lamictal; Benadryl; Tegretol; Nasal Spray



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014